Last reviewed · How we verify
NCT04885985
ACOART BTK RENEW：A Post Market Clinical Study
NA trial testing DEB catheter in Peripheral Artery Disease in 107 participants. Currently enrolling.
1 August 2024
Quick facts
| Lead sponsor | Acotec Scientific Co., Ltd |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 107 |
| Start date | 31 December 2021 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 April 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- DEB catheter
Conditions studied
- Peripheral Artery Disease — all drugs for Peripheral Artery Disease →
Sponsor
Acotec Scientific Co., Ltd
Who can join
Adults 18 to 75, any sex, with Peripheral Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this prospective, multi-center, single arm study is to obtain further data on the safety and performance of the Acotec Litos\&Tulip Drug-coated Balloon catheters in the treatment of lesions in below-the-knee artery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04885985
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Artery Disease
Currently open trials in the same condition.
- NCT07374601 — The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease · recruiting
- NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
- NCT04433572 — Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee · Phase 3 · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT07012070 — Improving Walking Performance in Patients With Peripheral Artery Disease Through Wearable Activity Trackers · NA · recruiting
Other Acotec Scientific Co., Ltd trials
Trials by the same sponsor.
- NCT05246410 — A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. · NA · unknown
- NCT04899583 — ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon · NA · unknown
- NCT04631055 — AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis · NA · completed
- NCT04627870 — ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis · NA · recruiting
- NCT04658901 — ACOART RF CLOSURE:Radiofrequency for Varicose Veins of Lower Extremity in China · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04885985 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Acotec Scientific Co., Ltd
- Last refreshed: 1 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04885985.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing